| Product Code: ETC7906934 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Latvia`s import shipments of carcinoembryonic antigen in 2024 continued to be dominated by top exporting countries such as Metropolitan France, Germany, Lithuania, Poland, and the USA. The market concentration, as measured by the HHI, remained very high, indicating a strong presence of these key players. Despite a notable CAGR of 43.42% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -57.01%, suggesting potential shifts or challenges in the market dynamics during that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Carcinoembryonic Antigen Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Latvia Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Latvia Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Latvia |
4.2.2 Growing awareness about early cancer detection and screening |
4.2.3 Advancements in medical technology for CEA testing |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for diagnostic tests |
4.3.2 Limited healthcare budget and reimbursement policies |
4.3.3 Competition from alternative biomarkers for cancer detection |
5 Latvia Carcinoembryonic Antigen Market Trends |
6 Latvia Carcinoembryonic Antigen Market, By Types |
6.1 Latvia Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.4 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.1.5 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.6 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.7 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F |
6.1.8 Latvia Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Latvia Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Latvia Carcinoembryonic Antigen Market Imports from Major Countries |
8 Latvia Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Adoption rate of CEA testing in Latvia |
8.2 Number of healthcare facilities offering CEA testing services |
8.3 Research and development investment in CEA testing technologies |
9 Latvia Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Latvia Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Latvia Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024 |
10.2 Latvia Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |